
GMP-grade, research-grade, and cosmetic-grade peptides across 9 therapeutic categories. All products come with full CoA, HPLC, and MS documentation.
Showing 9 of 51 products

GLP-1 receptor agonist for type 2 diabetes and chronic weight management. Widely used in clinical and wellness protocols.

Dual GIP/GLP-1 receptor agonist. Superior weight loss efficacy with improved glycemic control in clinical trials.

Long-acting amylin analogue for appetite suppression and weight reduction. Often combined with semaglutide.

Triple agonist targeting GLP-1, GIP, and glucagon receptors. Promising next-generation obesity treatment.

Modified fragment of human growth hormone. Stimulates fat metabolism without affecting blood sugar or growth.

Native GLP-1 receptor agonist. Regulates glucose-dependent insulin secretion and gastric emptying.

GLP-1/glucagon dual receptor agonist developed for obesity and NASH. Strong clinical pipeline in Asia.

GLP-1/glucagon receptor dual agonist. Investigated for obesity and metabolic-associated steatohepatitis (MASH).

GLP-1 receptor agonist with C16 fatty acid conjugation for extended half-life. Proven weight management therapy.
We synthesize any sequence at any scale — from milligram research quantities to multi-kilogram commercial batches. OEM, private label, and GMP manufacturing available. Response within 24 hours.
We use cookies
We use essential cookies to make our site work, and optional analytics & preference cookies to improve your experience. See our Cookie Policy for details.